The presence of acylated homoserine lactones and diffusible signal factor in bronchoalveolar lavage fluid from horses with clinical exacerbation of severe equine asthma.

Researchers tested bronchoalveolar fluid from 20 horses with a flare of severe equine asthma to see if bacterial “communication” chemicals used by common human biofilm-forming lung pathogens were present, but none were detected. Pseudomonas aeruginosa was not cultured, Stenotrophomonas maltophilia was found in 3 horses, and four targeted quorum-sensing molecules were absent by liquid chromatography–tandem mass spectrometry.

Background and rationale

• Many chronic lung diseases involve bacteria that coordinate behavior via quorum sensing (QS), producing biofilms that protect them from host defenses and antibiotics.
• In humans with COPD, asthma, and cystic fibrosis, pathogens such as Pseudomonas aeruginosa and Stenotrophomonas maltophilia use QS molecules—especially acylated homoserine lactones (AHLs) and diffusible signal factors (DSFs)—to regulate virulence and biofilm formation.
• Severe equine asthma (SEA) shares clinical and inflammatory features with these human conditions, raising the question of whether similar biofilm-driven bacterial mechanisms contribute to disease in horses.

Study objective and hypothesis

• Objective: Determine whether QS molecules associated with biofilm formation by P. aeruginosa and S. maltophilia are present in the lower airways of horses during SEA exacerbation.
• Hypothesis: AHLs (C4-HSL, C6-HSL, 3-oxo-C12-HSL) from P. aeruginosa and a DSF (11-methyl-2-dodecenoic acid) from S. maltophilia would be detectable in bronchoalveolar lavage fluid (BALf) from affected horses.

Methods at a glance

• Population and sampling: BALf collected from 20 horses experiencing clinical exacerbation of SEA.
• Microbiology: Standard culture performed to identify the presence of target pathogens (P. aeruginosa, S. maltophilia).
• Chemical analytics: Targeted liquid chromatography coupled to tandem mass spectrometry (LC–MS/MS) used to test for four QS molecules: C4-HSL, C6-HSL, 3-oxo-C12-HSL (AHLs), and 11-methyl-2-dodecenoic acid (a DSF).

Results

• Bacterial culture: Stenotrophomonas maltophilia was cultured in 3 of 20 horses; Pseudomonas aeruginosa was not identified in any sample.
• Quorum-sensing molecules: None of the targeted signals (C4-HSL, C6-HSL, 3-oxo-C12-HSL, or 11-methyl-2-dodecenoic acid) were detected in any BALf sample by LC–MS/MS.

Interpretation

• The absence of both P. aeruginosa and its hallmark AHLs, along with non-detection of the S. maltophilia DSF even in culture-positive horses, suggests that QS-regulated biofilm virulence typical of these human pathogens is not a prominent feature in SEA during clinical exacerbation.
• SEA pathogenesis may be driven more by non-bacterial triggers (e.g., environmental particulates, allergens) and host inflammatory responses than by classic biofilm-forming Gram-negative pathogens seen in chronic human airway disease.

Alternative explanations and limitations

• Targeted scope: Only four QS molecules were assayed; other relevant signals (e.g., Pseudomonas quinolone signal PQS/HHQ, AI-2, or Gram-positive peptide signals) were not evaluated.
• Detection constraints: QS molecules can be unstable (AHLs undergo lactonolysis at neutral-to-alkaline pH), sequestered by mucus, degraded by host/bacterial enzymes, or present below the assay’s limit of detection—any of which could yield false negatives.
• Sampling issues: Biofilms can be patchy and adherent; lavage may not capture airway wall–associated communities where QS signals concentrate.
• Microbiological sensitivity: Culture may miss low-abundance or fastidious organisms; culture-negative results do not exclude their presence.
• Study design: The sample size (n=20) is modest, and the absence of a healthy or remission control group limits comparison; details such as prior antimicrobial use, timing relative to exacerbation onset, and analytical LOD/LOQ were not specified in the abstract.

Clinical and scientific implications

• For clinicians: Findings do not support routine targeting of Pseudomonas- or Stenotrophomonas-type biofilm QS systems in SEA; management should continue to prioritize environmental control, bronchodilation, and anti-inflammatory therapy.
• For researchers: The microbial ecology of equine lower airways during SEA may differ meaningfully from human COPD/CF, cautioning against direct translational assumptions from human biofilm paradigms.
• For antimicrobial strategy: Broad anti-biofilm or QS-inhibiting approaches aimed at AHL/DSF circuits linked to human pathogens may have limited utility in SEA without evidence of target presence.

Recommendations for future work

• Broaden molecular targets: Include PQS/HHQ, AI-2, additional DSF-family members, and peptide-based QS signals used by Gram-positive bacteria.
• Enhance detection: Employ solid-phase extraction to concentrate analytes, stable isotope–labeled internal standards, and report LOD/LOQ to contextualize non-detects; assess BALf pH and lactonase activity that can degrade AHLs.
• Use culture-independent profiling: Apply 16S rRNA sequencing, shotgun metagenomics, and metatranscriptomics to map microbial communities and QS gene expression (e.g., lasI/rhlI, rpfF).
• Localize biofilms: Utilize microscopy (e.g., confocal imaging with biofilm stains) and in situ hybridization to detect airway wall–associated biofilms not sampled by lavage.
• Comparative cohorts: Include healthy controls and SEA horses in remission; perform longitudinal sampling across exacerbation and recovery to capture dynamic QS activity.
• Clinical correlates: Pair microbiological and QS data with inflammation markers, lung function, and treatment history to link signals with disease activity.

Context within human–equine respiratory disease parallels

• Despite overlapping clinical phenotypes, the airway microbiological drivers of chronic inflammation may diverge between species; SEA may not rely on the same QS-governed biofilm pathogens that dominate in human CF/COPD airways.

Bottom line

• In horses with exacerbated SEA, neither P. aeruginosa nor its key AHL signals were detected, and although S. maltophilia appeared in a minority of samples, its DSF signal was absent. These results argue against a major role for these human-associated QS biofilm mechanisms in SEA—at least under the conditions studied.